Nephrogenic systemic fibrosis: Clinicopathological definition and workup recommendations

Journal of the American Academy of Dermatology

Volumn 65, Issue 6, 2011, Pages

  Girardi, Michael ^a   Kay, Jonathan ^b   Elston, Dirk M ^c   Leboit, Philip E ^d   Abu Alfa, Ali ^a   Cowper, Shawn E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biopsy; contractures; contrast; diagnosis; gadolinium; magnetic resonance imaging; nephrogenic fibrosing dermopathy; nephrogenic systemic fibrosis; recommendations; renal disease; workup

Indexed keywords

GADOLINIUM;

ARTICLE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; LABORATORY TEST; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

EID: 81155152680     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.08.041     Document Type: Article

References (23)

1. S.E. Cowper, H.S. Robin, S.M. Steinberg, L.D. Su, S. Gupta, and P.E. LeBoit Scleromyxedema-like cutaneous diseases in renal-dialysis patients Lancet 356 2000 1000 1001
2. S.E. Cowper, L.D. Su, J. Bhawan, H.S. Robin, and P.E. LeBoit Nephrogenic fibrosing dermopathy Am J Dermatopathol 23 2001 383 393 (Pubitemid 32938907)
3. Cowper SE. International Nephrogenic Systemic Fibrosis Registry 2001-2011. Available from: URL: http://www.icnsfr.org. Accessed September 15, 2009.
4. R.L. Mehta, J.A. Kellum, S.V. Shah, B.A. Molitoris, C. Ronco, D.G. Warnock Acute Kidney Injury Network Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2007 R31
5. F. Jan, J.M. Segal, J. Dyer, P. LeBoit, E. Siegfried, and I.J. Frieden Nephrogenic fibrosing dermopathy: two pediatric cases J Pediatr 143 2003 678 681 (Pubitemid 37452802)
6. S.E. Cowper Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy Am J Kidney Dis 46 2005 763 765 (Pubitemid 41383957)
7. D.S. Goddard, C.C. Magee, A.J. Lazar, and D.M. Miller Nephrogenic fibrosing dermopathy with recurrence after allograft failure J Am Acad Dermatol 56 Suppl 2007 S109 S111
8. T. Grobner Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21 2006 3604 3605
9. Centers for Disease Control and Prevention Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents-St Louis, Missouri, 2002-2006 MMWR Morb Mortal Wkly Rep 56 2007 137 141
10. E.A. Sadowski, L.K. Bennett, M.R. Chan, A.L. Wentland, A.L. Garrett, and R.W. Garrett Nephrogenic systemic fibrosis: risk factors and incidence estimation Radiology 243 2007 148 157 (Pubitemid 46579705)
11. W.A. High, R.A. Ayers, and S.E. Cowper Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis J Am Acad Dermatol 56 2007 710 712 (Pubitemid 46400200)
12. A. Deo, M. Fogel, and S.E. Cowper Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure Clin J Am Soc Nephrol 2 2007 264 267
13. T.C. Lauenstein, K. Salman, R. Morreira, S. Tata, D. Tudorascu, and G. Baramidze Nephrogenic systemic fibrosis: center case review J Magn Reson Imaging 26 2007 1198 1203 (Pubitemid 350058286)
14. D.J. Todd, A. Kagan, L.B. Chibnik, and J. Kay Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure Arthritis Rheum 56 2007 3433 3441 (Pubitemid 47585439)
15. M.R. Prince, H. Zhang, M. Morris, J.L. MacGregor, M.E. Grossman, and J. Silberzweig Incidence of nephrogenic systemic fibrosis at two large medical centers Radiology 248 2008 807 816
16. H.H. Abujudeh, R. Kaewlai, A. Kagan, L.B. Chibnik, R.M. Nazarian, and W.A. High Nephrogenic systemic fibrosis in patients following gadopentetate dimeglumine exposure: a case series of 36 patients Radiology 253 2009 81 89
17. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
18. M. Koenig, M. Dieudé, and J.L. Senécal Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies Autoimmun Rev 7 2008 588 593
19. W. Kitamura, Y. Matsuoka, S. Miyagawa, and K. Sakamoto Immunochemical analysis of the monoclonal paraprotein in scleromyxedema J Invest Dermatol 70 1978 305 308 (Pubitemid 8369137)
20. A. Rebora, and F. Rongioletti Mucinoses J.L. Bolognia, J.L. Jorizzo, R.P. Rapini, Dermatology 2003 Mosby London 647 652
21. V. Falanga Systemic sclerosis J.L. Bolognia, J.L. Jorizzo, R.P. Rapini, Dermatology 2003 Mosby London 625 630
22. K.B. Cordova, T.J. Oberg, M. Malik, and L. Robinson-Bostom Dermatologic conditions seen in end-stage renal disease Semin Dial 22 2009 45 55
23. J. Bhawan, B.L. Swick, A.B. Koff, and M.S. Stone Sclerotic bodies in nephrogenic systemic fibrosis: a new histopathologic finding J Cutan Pathol 36 2009 548 552